JP2017526614A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526614A5 JP2017526614A5 JP2016563838A JP2016563838A JP2017526614A5 JP 2017526614 A5 JP2017526614 A5 JP 2017526614A5 JP 2016563838 A JP2016563838 A JP 2016563838A JP 2016563838 A JP2016563838 A JP 2016563838A JP 2017526614 A5 JP2017526614 A5 JP 2017526614A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- cycloalkyl
- aryl
- heterocycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(CC(*)(*)C(C)*C1)*(C)N1C([C@](*)NC(C1=CC=CC(C)(*)C=C1)=O)=O Chemical compound CC(CC(*)(*)C(C)*C1)*(C)N1C([C@](*)NC(C1=CC=CC(C)(*)C=C1)=O)=O 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461983146P | 2014-04-23 | 2014-04-23 | |
| US61/983,146 | 2014-04-23 | ||
| PCT/US2015/026811 WO2015175171A1 (en) | 2014-04-23 | 2015-04-21 | Substituted n-(2-(amino)-2-oxoethyl)benzamide inhibitors of autotaxin and their preparation and use in the treatment of lpa-dependent or lpa-mediated diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019170253A Division JP2020007360A (ja) | 2014-04-23 | 2019-09-19 | オートタキシンの置換ｎ−（２−アミノ）−２−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにｌｐａ依存性またはｌｐａ媒介性疾患の処置における使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017526614A JP2017526614A (ja) | 2017-09-14 |
| JP2017526614A5 true JP2017526614A5 (enExample) | 2018-05-24 |
| JP6592008B2 JP6592008B2 (ja) | 2019-10-16 |
Family
ID=54480420
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016563838A Expired - Fee Related JP6592008B2 (ja) | 2014-04-23 | 2015-04-21 | オートタキシンの置換ｎ−（２−アミノ）−２−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにｌｐａ依存性またはｌｐａ媒介性疾患の処置における使用 |
| JP2019170253A Pending JP2020007360A (ja) | 2014-04-23 | 2019-09-19 | オートタキシンの置換ｎ−（２−アミノ）−２−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにｌｐａ依存性またはｌｐａ媒介性疾患の処置における使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019170253A Pending JP2020007360A (ja) | 2014-04-23 | 2019-09-19 | オートタキシンの置換ｎ−（２−アミノ）−２−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにｌｐａ依存性またはｌｐａ媒介性疾患の処置における使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20170037007A1 (enExample) |
| EP (1) | EP3134079A4 (enExample) |
| JP (2) | JP6592008B2 (enExample) |
| CN (1) | CN107205972A (enExample) |
| BR (1) | BR112016024473A2 (enExample) |
| WO (1) | WO2015175171A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201607920RA (en) | 2014-04-04 | 2016-10-28 | X Rx Inc | Substituted spirocyclic inhibitors of autotaxin |
| EP3428150B1 (en) | 2016-03-11 | 2023-07-12 | Takeda Pharmaceutical Company Limited | Aromatic ring compound having a cholinergic muscarine m1 receptor positive allosteric modulator activity |
| CN117003875A (zh) | 2017-09-29 | 2023-11-07 | 第一三共株式会社 | 抗体或其功能性片段、多核苷酸、表达载体、宿主细胞、糖链重构抗体、药物组合物、应用 |
| CN108753699B (zh) * | 2018-06-19 | 2021-04-30 | 青岛农业大学 | 一种玉米赤霉烯酮对猪卵母细胞体外发育危害的挽救方法 |
| TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
| SG11202109860VA (en) * | 2019-03-25 | 2021-10-28 | Daiichi Sankyo Co Ltd | Anti-her2 antibody-pyrrolobenzodiazepine derivative conjugate |
| WO2021122645A1 (en) | 2019-12-20 | 2021-06-24 | Syngenta Crop Protection Ag | Pesticidally active azole-amide compounds |
| US12383547B2 (en) | 2020-07-01 | 2025-08-12 | Vanderbilt University | Methods of treatment for a kidney disease |
| CN113943274B (zh) * | 2020-07-16 | 2025-07-15 | 武汉人福创新药物研发中心有限公司 | 酰胺类化合物及其制备方法 |
| CN112675308B (zh) * | 2020-12-09 | 2023-05-05 | 中国人民解放军军事科学院军事医学研究院 | 抑制enpp2基因和/或蛋白表达的物质在制备治疗多发性骨髓瘤的药物中的应用 |
| JP2024502337A (ja) | 2021-01-05 | 2024-01-18 | ザイダス ライフサイエンシズ リミティド | オートタキシンの新規阻害剤 |
| JP7656367B2 (ja) * | 2021-10-01 | 2025-04-03 | ネクストジェン バイオサイエンス カンパニー リミテッド | 新規なピペリジン誘導体及びそれを含むオートタキシン阻害用薬学組成物 |
| CN121181427A (zh) * | 2025-11-25 | 2025-12-23 | 天津楷特药业有限公司 | 一种苯并环酮甲酸酯类化合物的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP1654A (en) * | 1999-03-24 | 2006-09-01 | Anormed Inc | Chemokine receptor binding heterocyclic compounds. |
| GB0030303D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| ATE308537T1 (de) * | 2001-05-10 | 2005-11-15 | Solvay Pharm Gmbh | Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| EP1597256A1 (en) * | 2003-02-21 | 2005-11-23 | Pfizer Inc. | N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors |
| WO2004076418A1 (en) * | 2003-02-28 | 2004-09-10 | Galderma Research & Development, S.N.C. | Ligands that modulate lxr-type receptors |
| JP4761756B2 (ja) * | 2003-10-31 | 2011-08-31 | 大塚製薬株式会社 | ２，３−ジヒドロイミダゾ［２，１−ｂ］オキサゾ−ル化合物 |
| US7601844B2 (en) * | 2006-01-27 | 2009-10-13 | Bristol-Myers Squibb Company | Piperidinyl derivatives as modulators of chemokine receptor activity |
| EP2007723A2 (en) * | 2006-04-11 | 2008-12-31 | Novartis AG | Organic compounds |
| HUP0600808A3 (en) * | 2006-10-27 | 2008-09-29 | Richter Gedeon Nyrt | New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them |
| MY161831A (en) * | 2007-10-27 | 2017-05-15 | Richter Gedeon Nyrt | New non-peptide derivatives as bradykinin b1 antagonists |
| MX2010010241A (es) * | 2008-03-20 | 2010-12-06 | Forest Lab Holdings Ltd | Derivados de piperidina novedosos como inhibidores de estearoil-coa desaturasa. |
| WO2010065799A2 (en) * | 2008-12-04 | 2010-06-10 | Palatin Technologies, Inc. | Amine substituted piperidine melanocortin receptor-specific compounds |
| WO2010091164A1 (en) * | 2009-02-06 | 2010-08-12 | Exelixis, Inc. | Inhibitors of glucosylceramide synthase |
| DE102009033392A1 (de) * | 2009-07-16 | 2011-01-20 | Merck Patent Gmbh | Heterocyclische Verbindungen als Autotaxin-Inhibitoren II |
| IN2012DN00754A (enExample) * | 2009-08-04 | 2015-06-19 | Amira Pharmaceuticals Inc | |
| US8497371B2 (en) * | 2009-10-26 | 2013-07-30 | University Of Memphis Research Foundation | Pipemidic acid derivative autotaxin inhibitors |
| US8518945B2 (en) * | 2010-03-22 | 2013-08-27 | Hoffmann-La Roche Inc. | Pyrrolopyrazine kinase inhibitors |
| JP2011219368A (ja) * | 2010-04-02 | 2011-11-04 | Daiichi Sankyo Co Ltd | Ｎ−サリチルアミノ酸誘導体 |
| EP2606031B1 (en) * | 2010-08-20 | 2017-09-27 | Amira Pharmaceuticals, Inc. | Autotaxin inhibitors and uses thereof |
| WO2012166415A1 (en) * | 2011-05-27 | 2012-12-06 | Amira Pharmaceuticals, Inc. | Heterocyclic autotaxin inhibitors and uses thereof |
| JP6158817B2 (ja) * | 2011-10-28 | 2017-07-05 | インヒビタクシン リミテッド | 治療に有用なピリダジン誘導体 |
| DK2897939T3 (en) * | 2012-09-21 | 2017-05-08 | Sanofi Sa | BENZOIMIDAZOLCARBOXYL ACID AMIDE DERIVATIVES FOR THE TREATMENT OF METABOLIC OR CARDIOVASCULAR DISEASES |
-
2015
- 2015-04-21 WO PCT/US2015/026811 patent/WO2015175171A1/en not_active Ceased
- 2015-04-21 CN CN201580031612.XA patent/CN107205972A/zh active Pending
- 2015-04-21 BR BR112016024473A patent/BR112016024473A2/pt not_active Application Discontinuation
- 2015-04-21 US US15/303,848 patent/US20170037007A1/en not_active Abandoned
- 2015-04-21 JP JP2016563838A patent/JP6592008B2/ja not_active Expired - Fee Related
- 2015-04-21 EP EP15792570.2A patent/EP3134079A4/en not_active Withdrawn
-
2019
- 2019-09-19 JP JP2019170253A patent/JP2020007360A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017526614A5 (enExample) | ||
| JP2017513932A5 (enExample) | ||
| JP2016500661A5 (enExample) | ||
| JP2018519323A5 (enExample) | ||
| JP2017525757A5 (enExample) | ||
| JP2019537605A5 (enExample) | ||
| JP2020521767A5 (enExample) | ||
| JP2010532386A5 (enExample) | ||
| JP2016512515A5 (enExample) | ||
| JP2016535772A5 (enExample) | ||
| IL295956A (en) | Heterocyclic amides and their use for modulating splicing | |
| JP2017511794A5 (enExample) | ||
| JP2014505660A5 (enExample) | ||
| RU2009119290A (ru) | Производные гидантоина, используемые в качестве ингибиторов ммр | |
| JP2010539110A5 (enExample) | ||
| JP2010540525A5 (enExample) | ||
| JP2019536785A5 (enExample) | ||
| JP2009534404A5 (enExample) | ||
| JP2013523803A5 (enExample) | ||
| JP2009515988A5 (enExample) | ||
| JP2017500334A5 (enExample) | ||
| JP2018528942A5 (enExample) | ||
| JP2016525136A5 (enExample) | ||
| JP2016532673A5 (enExample) | ||
| JP2019513745A5 (enExample) |